CytomX Therapeutics Inc (NASDAQ:CTMX)

1.34
Delayed Data
As of Nov 28
 +0.02 / +1.50%
Today’s Change
1.04
Today|||52-Week Range
3.02
-16.25%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$91.1M

Company Description

CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company, which engages in the development of conditionally activated, biologics localized to the tumor microenvironment. The company was founded by Frederick W. Gluck and Nancy E. Stagliano in September 2010 and is headquartered in South San Francisco, CA.

Contact Information

CytomX Therapeutics, Inc.
151 Oyster Point Boulevard
South San Francisco California 94080-1913
P:(605) 515-3185
Investor Relations:

Employees

Shareholders

Other institutional38.22%
Individual stakeholders23.99%
Mutual fund holders10.35%

Top Executives

Sean A. McCarthyChairman, President & Chief Executive Officer
Chris OgdenChief Financial & Accounting Officer
Marcia P. BelvinChief Scientific Officer & Senior Vice President
Yu Waye ChuChief Medical Officer
Lloyd A. RowlandSecretary, Compliance Officer & General Counsel